Zimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company
Needham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
